Logo path
/content/dam/pmequitypartner/portfolio-products/company-logos/Biognosys V3.png
Leading global proteomics company that offers large-scale proteomics solutions based on proprietary mass spectrometry technology

Biognosys is the world leader in next-generation proteomics contract research services to support pharma and biotech research and clinical development. The decoding of the proteome is revolutionizing the way diseases are diagnosed, treated, and prevented. Biognosys invents and provides patented proteomics solutions at the quality, scale, and speed required to transform R&D, clinical trials, and clinical decision-making.

PM Equity Partner has exited its investment in Biognosys.

Website url
Top Image
/content/dam/pmequitypartner/portfolio-products/biognosys 1.PNG
Left Image
/content/dam/pmequitypartner/portfolio-products/Biognosys 2.PNG
Right Image
/content/dam/pmequitypartner/portfolio-products/Biognosys 3.PNG